IFM Investors Pty Ltd bought a new position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The fund bought 41,177 shares of the company's stock, valued at approximately $1,314,000.
Other large investors have also added to or reduced their stakes in the company. Smartleaf Asset Management LLC grew its position in shares of Bath & Body Works by 135.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock valued at $39,000 after acquiring an additional 582 shares during the period. Steward Partners Investment Advisory LLC lifted its stake in shares of Bath & Body Works by 17.1% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 4,216 shares of the company's stock valued at $163,000 after buying an additional 615 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Bath & Body Works by 13.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,704,625 shares of the company's stock valued at $66,088,000 after buying an additional 195,813 shares in the last quarter. Victory Capital Management Inc. lifted its stake in shares of Bath & Body Works by 25.2% during the 4th quarter. Victory Capital Management Inc. now owns 45,834 shares of the company's stock valued at $1,777,000 after buying an additional 9,215 shares in the last quarter. Finally, M&T Bank Corp lifted its stake in shares of Bath & Body Works by 20.3% during the 4th quarter. M&T Bank Corp now owns 17,688 shares of the company's stock valued at $686,000 after buying an additional 2,984 shares in the last quarter. Institutional investors own 95.14% of the company's stock.
Bath & Body Works Stock Down 1.4%
Bath & Body Works stock traded down $0.48 during midday trading on Wednesday, reaching $33.03. The stock had a trading volume of 5,959,189 shares, compared to its average volume of 5,213,237. Bath & Body Works, Inc. has a 52-week low of $24.94 and a 52-week high of $41.87. The firm has a market cap of $6.99 billion, a price-to-earnings ratio of 8.81, a price-to-earnings-growth ratio of 1.10 and a beta of 1.72. The company has a fifty day moving average of $29.93 and a 200 day moving average of $32.62.
Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. The company had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.42 billion. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The firm's revenue for the quarter was up 2.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.38 EPS. Equities research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.
Bath & Body Works Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 6th were paid a dividend of $0.20 per share. The ex-dividend date was Friday, June 6th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.42%. Bath & Body Works's dividend payout ratio is presently 21.33%.
Analyst Ratings Changes
A number of research analysts recently weighed in on BBWI shares. Piper Sandler set a $39.00 target price on shares of Bath & Body Works and gave the company an "overweight" rating in a research note on Thursday, May 15th. Barclays decreased their price target on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating on the stock in a research note on Friday, May 30th. UBS Group boosted their price target on shares of Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a research note on Tuesday, May 20th. JPMorgan Chase & Co. boosted their price target on shares of Bath & Body Works from $41.00 to $43.00 and gave the stock an "overweight" rating in a research note on Monday, May 19th. Finally, Telsey Advisory Group reiterated an "outperform" rating and issued a $38.00 price target (down previously from $43.00) on shares of Bath & Body Works in a research note on Thursday, May 29th. Four equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Bath & Body Works has a consensus rating of "Moderate Buy" and an average target price of $42.00.
Read Our Latest Research Report on Bath & Body Works
Bath & Body Works Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Articles
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
